P. C. Dowling

1.5k total citations
31 papers, 1.1k citations indexed

About

P. C. Dowling is a scholar working on Pathology and Forensic Medicine, Oncology and Epidemiology. According to data from OpenAlex, P. C. Dowling has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 8 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in P. C. Dowling's work include Multiple Sclerosis Research Studies (14 papers), Polyomavirus and related diseases (5 papers) and Peripheral Neuropathies and Disorders (4 papers). P. C. Dowling is often cited by papers focused on Multiple Sclerosis Research Studies (14 papers), Polyomavirus and related diseases (5 papers) and Peripheral Neuropathies and Disorders (4 papers). P. C. Dowling collaborates with scholars based in United States, Switzerland and France. P. C. Dowling's co-authors include S. D. Cook, Walter Husar, Joseph Menonna, Guanning Shang, John N. Whitaker, Benjamin M. Blumberg, Margaret R. Murray, S. Bansil, Christine Rohowsky‐Kochan and Xue Ming and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

P. C. Dowling

31 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. C. Dowling United States 17 372 272 249 210 202 31 1.1k
Emilia L. Oleszak United States 19 466 1.3× 474 1.7× 309 1.2× 137 0.7× 148 0.7× 46 1.4k
Foroozan Mokhtarian United States 16 257 0.7× 486 1.8× 145 0.6× 174 0.8× 141 0.7× 39 1.0k
Joseph Menonna United States 11 161 0.4× 215 0.8× 251 1.0× 95 0.5× 341 1.7× 20 911
H P Ekre Sweden 11 335 0.9× 650 2.4× 187 0.8× 224 1.1× 154 0.8× 13 1.2k
Ronald S. Murray United States 18 611 1.6× 759 2.8× 239 1.0× 364 1.7× 270 1.3× 34 1.8k
B. G. Weinshenker United States 10 722 1.9× 225 0.8× 187 0.8× 586 2.8× 138 0.7× 17 1.1k
Michael T. Liu United States 10 241 0.6× 599 2.2× 99 0.4× 85 0.4× 180 0.9× 10 1.1k
J R Richert United States 13 712 1.9× 892 3.3× 244 1.0× 202 1.0× 276 1.4× 31 1.7k
Ying C. Q. Zang United States 26 653 1.8× 937 3.4× 242 1.0× 119 0.6× 200 1.0× 35 1.6k
Yuji Kawano Japan 20 613 1.6× 398 1.5× 234 0.9× 422 2.0× 71 0.4× 39 1.3k

Countries citing papers authored by P. C. Dowling

Since Specialization
Citations

This map shows the geographic impact of P. C. Dowling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. C. Dowling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. C. Dowling more than expected).

Fields of papers citing papers by P. C. Dowling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. C. Dowling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. C. Dowling. The network helps show where P. C. Dowling may publish in the future.

Co-authorship network of co-authors of P. C. Dowling

This figure shows the co-authorship network connecting the top 25 collaborators of P. C. Dowling. A scholar is included among the top collaborators of P. C. Dowling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. C. Dowling. P. C. Dowling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ming, Xue, et al.. (2001). Proliferating oligodendrocytes are present in both active and chronic inactive multiple sclerosis plaques. Journal of Neuroscience Research. 65(4). 308–317. 28 indexed citations
2.
Vuguin, Patricia, Alan Shanske, Jay W. Ellison, et al.. (1998). The effect of growth hormone treatment in idiopathic short stature with SHOX mutation • 496. Pediatric Research. 43. 87–87. 3 indexed citations
3.
Shanske, Alan, et al.. (1998). The effect of growth hormone treatment in idiopathic short stature with shox mutation. Growth Hormone & IGF Research. 8(4). 320–320. 1 indexed citations
4.
Cook, S. D., Leo Wolansky, Joseph Guarnaccia, et al.. (1997). Modified total lymphoid irradiation and low dose corticosteroids in progressive multiple sclerosis. Journal of the Neurological Sciences. 152(2). 172–181. 11 indexed citations
5.
Dowling, P. C., et al.. (1996). Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain.. The Journal of Experimental Medicine. 184(4). 1513–1518. 244 indexed citations
6.
Cook, S. D., S. Bansil, Geremia Zito Marinosci, et al.. (1995). Combination total lymphoid irradiation and low-dose corticosteroid therapy for progressive multiple sclerosis. Acta Neurologica Scandinavica. 91(1). 22–27. 11 indexed citations
7.
Cook, S. D., Christine Rohowsky‐Kochan, S. Bansil, & P. C. Dowling. (1995). Evidence for multiple sclerosis as an infectious disease. Acta Neurologica Scandinavica. 91(S161). 34–42. 58 indexed citations
8.
Dowling, P. C., et al.. (1993). Detection of bcl-2/JH rearrangement in follicular and diffuse lymphoma: concordant results of peripheral blood and bone marrow analysis at diagnosis. British Journal of Cancer. 67(5). 922–925. 37 indexed citations
9.
Cook, S. D., Christine Rohowsky‐Kochan, Leonard Bielory, et al.. (1992). Intravenous gamma globulin in progressive MS. Acta Neurologica Scandinavica. 86(2). 171–175. 33 indexed citations
10.
Sharer, Leroy R., P. C. Dowling, Jennifer Michaels, et al.. (1990). Spinal cord disease in children with HIV‐1 infection: a combined molecular biological and neuropathological study*. Neuropathology and Applied Neurobiology. 16(4). 317–331. 42 indexed citations
11.
Marinosci, Geremia Zito, Richard B. Devereux, Richard A. Friedman, et al.. (1988). Effect of total lymphoid irradiation on functional status in chronic multiple sclerosis: importance of lymphopenia early after treatment--the pros.. PubMed. 38(7 Suppl 2). 32–7. 17 indexed citations
12.
Marinosci, Geremia Zito, et al.. (1988). Effect of Lymphoid Irradiation on Clinical Course, Lymphocyte Count, and T‐Cell Subsets in Chronic Progressive Multiple Sclerosis. Annals of the New York Academy of Sciences. 540(1). 533–534. 1 indexed citations
13.
Cook, S. D., Joel D. MacDonald, Walter N. Tapp, D C Poskanzer, & P. C. Dowling. (1988). Multiple sclerosis in the Shetland Islands: an update. Acta Neurologica Scandinavica. 77(2). 148–151. 31 indexed citations
14.
Marinosci, Geremia Zito, et al.. (1984). Total Lymphoid Irradiation in Chronic Progressive Multiple Sclerosis: A Preliminary Report. Annals of the New York Academy of Sciences. 436(1). 397–409. 3 indexed citations
15.
Dowling, P. C., Colomba Giorgi, L. Roux, et al.. (1983). Molecular cloning of the 3'-proximal third of Sendai virus genome.. Proceedings of the National Academy of Sciences. 80(17). 5213–5216. 47 indexed citations
16.
Dowling, P. C., et al.. (1977). A POSSIBLE ASSOCIATION BETWEEN HOUSE PETS AND MULTIPLE SCLEROSIS. The Lancet. 309(8019). 980–982. 75 indexed citations
17.
Menonna, Joseph, Herman Chmel, Marilyn A. Menegus, P. C. Dowling, & S. D. Cook. (1977). Precipitating antibodies in mycoplasma infection. Journal of Clinical Microbiology. 5(6). 610–612. 7 indexed citations
18.
Dowling, P. C., et al.. (1976). Disease Markers in Acute Multiple Sclerosis. Archives of Neurology. 33(10). 668–670. 18 indexed citations
19.
Dowling, P. C. & S. D. Cook. (1968). The in vitro synthesis of a demyelinating factor by circulating immunocytes in EAE.. PubMed. 18(3). 295–6. 6 indexed citations
20.
Cook, S. D., et al.. (1962). Multiple sclerosis and pregnancy. American Journal of Obstetrics and Gynecology. 83(5). 689–699. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026